Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
about
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@nl
type
label
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@nl
prefLabel
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@en
Phase I and pharmacokinetics/p ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
Phase I and pharmacokinetics/p ...... nts with advanced solid tumors
@en
P2093
Hidenori Mizugaki
Hiroshi Nokihara
Hiroshi Wakui
Kazunori Honda
Mieko Matsuoka
Naoya Yamazaki
Noboru Yamamoto
Satoru Kitazono
Shigenobu Suzuki
Shinji Nakamichi
P2860
P2888
P304
P356
10.1007/S10637-015-0229-3
P577
2015-03-27T00:00:00Z